The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Cisplatin Nephrotoxicity: A Review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thadhani, R., Pascual, M., & Bonventre, J. V. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342207 · Cited by 1,417
Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor Response
Myers, C. E., McGuire, W. P., Liss, R. H., Ifrim, I., Grotzinger, K., & Young, R. C. (1977) · Science · doi:10.1126/science.877547 · Cited by 1,111
Arany, I., & Safirstein, R. L. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00089-5 · Cited by 906
TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity
Ramesh, G., & Reeves, W. B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15606 · Cited by 866
Acute renal failure: definitions, diagnosis, pathogenesis, and therapy
Schrier, R. W., Wang, W., Poole, B., & Mitra, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22353 · Cited by 683
Acute renal failure: definitions, diagnosis, pathogenesis, and therapy
Schrier, R. W., Wang, W., Poole, B., & Mitra, A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422353 · Cited by 642
Cellular accumulation of the anticancer agent cisplatin: A review
Gately, D., & Howell, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.221 · Cited by 572
Lieberthal, W., Triaca, V., & Levine, J. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.4.f700 · Cited by 449
Cisplatin Nephrotoxicity Is Critically Mediated via the Human Organic Cation Transporter 2
Ciarimboli, G., Ludwig, T., Lang, D., Pavenstädt, H., Koepsell, H., Piechota, H.-J., Haier, J., Jaehde, U., Zisowsky, J., & Schlatter, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61234-5 · Cited by 448
Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury
Deng, J., Kohda, Y., Chiao, H., Wang, Y., Hu, X., Hewitt, S. M., Miyaji, T., Mcleroy, P., Nibhanupudy, B., Li, S., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00043.x · Cited by 399
Anticancer Drug???Induced Kidney Disorders: Incidence, Prevention and Management
Kintzel, P. E. (2001) · Drug Safety · doi:10.2165/00002018-200124010-00003 · Cited by 355
Metabolism of Cisplatin to a Nephrotoxin in Proximal Tubule Cells
Townsend, D. M., Deng, M., Zhang, L., Lapus, M. G., & Hanigan, M. H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000042803.28024.92 · Cited by 317
Kuhlmann, M., Burkhardt, G., & Kohler, H. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.12.2478 · Cited by 290
TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure
Ramesh, G., & Reeves, W. B. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00101.2003 · Cited by 282
Nephrotoxicity and Hydration Management for Cisplatin, Carboplatin, and Ormaplatin
Cornelison, T. L., & Reed, E. (1993) · Gynecologic Oncology · doi:10.1006/gyno.1993.1184 · Cited by 270
p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice
Ramesh, G., & Reeves, W. B. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00401.2004 · Cited by 267
Kaushal, G. P., Kaushal, V., Hong, X., & Shah, S. V. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00026.x · Cited by 266
Review: Hypoxia-Inducible Factor-1 (HIF-1): A Novel Transcription Factor in Immune Reactions
Hellwig-Bürgel, T., Stiehl, D. P., Wagner, A. E., Metzen, E., & Jelkmann, W. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.297 · Cited by 254
Weijl, N. I., Elsendoorn, T. J., Lentjes, E. G. W. M., Hopman, G. D., Wipkink-Bakker, A., Zwinderman, A. H., Cleton, F. J., & Osanto, S. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.02.029 · Cited by 251
Lajer, H., & Daugaard, G. (1999) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0097 · Cited by 250
Holzer, A. K., Samimi, G., Katano, K., Naerdemann, W., Lin, X., Safaei, R., & Howell, S. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001198 · Cited by 245
Tsuruya, K., Ninomiya, T., Tokumoto, M., Hirakawa, M., Masutani, K., Taniguchi, M., Fukuda, K., Kanai, H., Kishihara, K., Hirakata, H., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00709.x · Cited by 241
Jo, S.-K., Cho, W. Y., Sung, S. A., Kim, H. K., & Won, N. H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67102.x · Cited by 235
Cisplatin nephrotoxicity: A review
Daugaard, G., & Abildgaard, U. (1989) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00694330 · Cited by 234
Naringenin attenuates cisplatin nephrotoxicity in rats
Badary, O. A., Abdel-Maksoud, S., Ahmed, W. A., & Owieda, G. H. (2005) · Life Sciences · doi:10.1016/j.lfs.2004.11.005 · Cited by 230
Assessment of Cisplatin-Induced Nephrotoxicity by Microarray Technology
Huang, Q. (2001) · Toxicological Sciences · doi:10.1093/toxsci/63.2.196 · Cited by 218
Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells
Arany, I., Megyesi, J. K., Kaneto, H., Price, P. M., & Safirstein, R. L. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00112.2004 · Cited by 215
Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-α
Ramesh, G., & Reeves, W. B. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00413.x · Cited by 196
Faubel, S., Ljubanovic, D., Reznikov, L., Somerset, H., Dinarello, C. A., & Edelstein, C. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.66010.x · Cited by 196
Metabolomic study of cisplatin-induced nephrotoxicity
Portilla, D., Li, S., Nagothu, K. K., Megyesi, J., Kaissling, B., Schnackenberg, L., Safirstein, R. L., & Beger, R. D. (2006) · Kidney International · doi:10.1038/sj.ki.5000433 · Cited by 180
Nephrotoxicity of platinum complexes is related to basolateral organic cation transport
Ludwig, T., Riethmüller, C., Gekle, M., Schwerdt, G., & Oberleithner, H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00720.x · Cited by 179
Relationship of Intracellular Calcium and Oxygen Radicals to Cisplatin-Related Renal Cell Injury
Kawai, Y., Nakao, T., Kunimura, N., Kohda, Y., & Gemba, M. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050661 · Cited by 176
Lynch, E. D., Gu, R., Pierce, C., & Kil, J. (2005) · Hearing Research · doi:10.1016/j.heares.2004.08.002 · Cited by 167
Vickers, A. E. M., Rose, K. L., Fisher, R. L., Saulnier, M., Sahota, P. S., & Bentley, P. (2004) · Toxicologic Pathology · doi:10.1080/01926230490508821 · Cited by 157
Chirino, Y. I., Hernández‐Pando, R., & Pedraza‐Chaverrí, J. (2004) · BMC Pharmacology · doi:10.1186/1471-2210-4-20 · Cited by 149
Current and future potential roles of the platinum drugs in the treatment of ovarian cancer
Piccart, M. J., Lamb, H., & Vermorken, J. B. (2001) · Annals of Oncology · doi:10.1023/a:1012259625746 · Cited by 139
Townsend, D. M., & Hanigan, M. H. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.142 · Cited by 138
Cisplatin Nephrotoxicity and Protection by Milk Thistle Extract in Rats
Karimi, G., Ramezani, M., & Tahoonian, Z. (2005) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/neh103 · Cited by 122
Cisplatin Nephrotoxicity Is Mediated by Deoxyribonuclease I
Basnakian, A. G., Apostolov, E. O., Yin, X., Napirei, M., Mannherz, H. G., & Shah, S. V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060494 · Cited by 115
Fibrate prevents cisplatin-induced proximal tubule cell death.
Nagothu, K. K., Bhatt, R., Kaushal, G., & Portilla, D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00739.x · Cited by 111
Role of early plasma membrane events in chemotherapy-induced cell death
Dimanche‐Boitrel, M., Meurette, O., Rébillard, A., & LACOUR, S. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.02.003 · Cited by 108
Hypoxia-inducible factor modulates tubular cell survival in cisplatin nephrotoxicity
Tanaka, T., Kojima, I., Ohse, T., Inagi, R., Miyata, T., Ingelfinger, J. R., Fujita, T., & Nangaku, M. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00081.2005 · Cited by 100
Schweyer, S., Soruri, A., Meschter, O., Heintze, A., Zschunke, F., Miosge, N., Thelen, P., Schlott, T., Radzun, H., & Fayyazi, A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601919 · Cited by 97
YILMAZ, H., İraz, M., SOGUT, S., Özyurt, H., Yıldırım, Z., Akyol, Ö., & Gergerlioğlu, H. S. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.03.003 · Cited by 97
The protective effect of melatonin on cisplatin nephrotoxicity
Şener, G., Şatıroğlu, H., Kabasakal, L., et al. (2000) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2000.tb00440.x · Cited by 80
Identification of Platform-Independent Gene Expression Markers of Cisplatin Nephrotoxicity
Thompson, K. L., Afshari, C. A., Amin, R. P., Bertram, T. A., Car, B. D., Cunningham, M. L., Kind, C. N., Kramer, J. A., Lawton, M. P., Mirsky, M. L., et al. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.6676 · Cited by 76
Role of poly(ADP-ribose)polymerase in cisplatin-induced injury in LLC-PK1 cells
Shino, Y., Itoh, Y., Kubota, T., Yano, T., Sendo, T., & Oishi, R. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00470-2 · Cited by 62
Cisplatin nephrotoxicity affects magnesium and calcium metabolism
Goren, M. P. (2003) · Medical and Pediatric Oncology · doi:10.1002/mpo.10335 · Cited by 55
Yamate, J., Sato, K., Ide, M., Nakanishi, M., Kuwamura, M., Sakuma, S., & Nakatsuji, S. (2002) · Veterinary Pathology · doi:10.1354/vp.39-3-322 · Cited by 55
Histopathological Study of Human Cisplatin Nephropathy
Tanaka, H., Ishikawa, E., Teshima, S., & Shimizu, E. (1986) · Toxicologic Pathology · doi:10.1177/019262338601400215 · Cited by 52
Thomas, M. C., Tikellis, C., Kantharidis, P., Burns, W. C., Cooper, M. E., & Forbes, J. M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070672 · Cited by 49
Clinical Nephrotoxins: Renal Injury from Drugs and Chemicals
Broe, M. E. D., Verpooten, G. A., Bennett, W. M., & Porter, G. A. (2003) · Springer eBooks · doi:10.1007/1-4020-2586-6 · Cited by 34
Stress response inhibits the nephrotoxicity of cisplatin
Hanigan, M. H., Deng, M., Zhang, L., et al. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00041.2003 · Cited by 31
Yamate, J., Machida, Y., Ide, M., Kuwamura, M., Sawamoto, O., & LaMarre, J. (2004) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2004.04.008 · Cited by 25
Cited by
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Mechanisms of Cisplatin Nephrotoxicity
Miller, R. P., Tadagavadi, R. K., Ramesh, G., & Reeves, W. B. (2010) · Toxins · doi:10.3390/toxins2112490 · Cited by 1,622
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
Jang, K.-J., Mehr, A. P., Hamilton, G. A., McPartlin, L. A., Chung, S., Suh, K.-Y., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40049b · Cited by 849
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Metadata
- Authors
- Yao, X., Panichpisal, K., Kurtzman, N., & Nugent, K.
- Venue
- The American Journal of the Medical Sciences
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 334
- Issue
- 2
- Pages
- 115-124
- ISSN
- 0002-9629 (ISSN-L)
- OpenAlex
- W2127618819
- Cited by
- 1,251
- References
- 54
- FWCI
- 19.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.